scholarly journals PIN34 COST-UTILITY ANALYSIS OF DIRECT ACTING ANTIVIRALS FOR EARLY-STAGE GENOTYPE 1 HCV PATIENTS IN BRAZIL

2020 ◽  
Vol 23 ◽  
pp. S174
Author(s):  
V.L. Ferreira ◽  
B. Riveros ◽  
L. Leonart ◽  
M.L.A. Pedroso ◽  
M.E. Nita ◽  
...  
Keyword(s):  
Early Stage ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Genotype 1 ◽  
Direct Acting Antivirals ◽  
Utility Analysis ◽  
Direct Acting

scholarly journals Cost-Utility Analysis of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C Genotype 1 and 6 in Vietnam

2020 ◽  
Vol 23 (9) ◽  
pp. 1180-1190 ◽  
Author(s):  
Ong The Due ◽  
Ammarin Thakkinstian ◽  
Montarat Thavorncharoensap ◽  
Abhasnee Sobhonslidsuk ◽  
Olivia Wu ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Genotype 1 ◽  
Direct Acting Antivirals ◽  
Utility Analysis ◽  
Direct Acting

Cost-utility analysis of second-generation direct-acting antivirals for hepatitis C: a systematic review

2018 ◽  
Vol 12 (12) ◽  
pp. 1251-1263 ◽  
Author(s):  
Jaume Puig-Junoy ◽  
Natàlia Pascual-Argente ◽  
Lluc Puig-Codina ◽  
Laura Planellas ◽  
Míriam Solozabal
Keyword(s):  
Systematic Review ◽  
Hepatitis C ◽  
Second Generation ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Direct Acting Antivirals ◽  
Utility Analysis ◽  
Direct Acting

Cost–utility analysis of ledipasvir/sofosbuvir for the treatment of genotype 1 chronic hepatitis C in Japan

2016 ◽  
Vol 33 (1) ◽  
pp. 11-21 ◽  
Author(s):  
Ataru Igarashi ◽  
Wentao Tang ◽  
Ines Guerra ◽  
Lucile Marié ◽  
Sandrine Cure ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Genotype 1 ◽  
Utility Analysis
Sign in / Sign up

Export Citation Format

Share Document